0.60Open0.60Pre Close0 Volume24 Open Interest19.00Strike Price0.00Turnover9051.58%IV7.05%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.60Extrinsic Value100Contract SizeAmericanOptions Type0.4053Delta0.1754Gamma30.52Leverage Ratio-676.8212Theta0.0000Rho12.37Eff Leverage0.0001Vega
Summit Therapeutics Stock Discussion
$Nxu Inc (NXU.US)$ grab some on your way out.
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
No comment yet